Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
Rosaria Di Lorenzo1, Alice Brogli21Department of Mental Health, AUSL-MODENA, Presidio Psichiatrico di Diagnosi e Cura 1, NOCSAE, Baggiovara, Modena, Italy; 2School of Specialization in Psychiatry, University of Modena e Reggio Emilia, Modena, ItalyAbstract: Olanzapine long-acting injection (OLAI) is...
Saved in:
Main Authors: | Rosaria Di Lorenzo, Alice Brogli |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/b7f92fe5a5164c52bd42c81a2c87c99e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
by: Ascher-Svanum H, et al.
Published: (2014) -
Long-acting injectable antipsychotics: focus on olanzapine pamoate
by: JP Lindenmayer
Published: (2010) -
Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses
by: Ciudad A, et al.
Published: (2013) -
Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia
by: Brasso C, et al.
Published: (2017) -
A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation
by: An, et al.
Published: (2015)